
HC seeks Centre’s response to firm’s plea to allow human trials of cancer vaccine
MUMBAI: The Bombay high court on Wednesday issued a notice to the central drug regulator to respond to a petition filed by a Nashik-based cancer research company seeking permission to conduct phase 1 human trials of its cancer immunotherapy drug, Per-C-Vax …